Table 2.

Transition probabilities applied in the model

Parameter		Probability	Reference
Discontinuation SLIT (5-grass tablet)	Year 1	0.29	[27]
	Year 2	0.28	[27]
Discontinuation SCIT (allergoid mix)	Year 1	0.41	[27]
	Year 2	0.34	[27]
Developing asthma with symptomatic treatment		0.0046	[28]
Relative risk developing asthma (AIT vs. symptomatic treatment)		0.505	[29,30]
All population mortality*		0.00046	[31]
Asthma mortality*		0.00069	[32]

*Probabilities represent mortality at start of the analysis (29 years).